Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company achieved a significant increase in net profit of 69.4% in 2024, driven by multi-channel and multi-brand growth strategies [6] - Revenue for 2024 reached 6.793 billion yuan, reflecting a year-on-year growth of 62.1% [6] - The main brand, Han Shu, showed strong performance with revenue of 5.591 billion yuan, up 80.9%, and is positioned as the second in online GMV among domestic beauty brands [7] - The company is expected to continue its growth trajectory with a projected net profit of 1.006 billion yuan in 2025, 1.258 billion yuan in 2026, and 1.532 billion yuan in 2027 [6] Financial Summary and Valuation Metrics - Revenue for 2023 was 4.191 billion yuan, with a projected increase to 8.496 billion yuan in 2025 and 10.242 billion yuan in 2026 [9] - The net profit for 2023 was 461 million yuan, expected to rise to 1.006 billion yuan in 2025 and 1.258 billion yuan in 2026 [9] - The gross margin for 2024 was 75.2%, an increase of 3.2 percentage points from the previous year [7] - The projected EPS for 2025 is 2.53 yuan, with a P/E ratio of 16.9 times [6][9]

丨证券研究报告丨 分析师及联系人 [Table_Author] 范超 李金宝 SAC：S0490513080001 SAC：S0490516040002 SFC：BQK473 港股研究丨公司点评丨华润建材科技（1313.HK） [Table_Title] 期待华南市场改善，公司业绩弹性释放 报告要点 [Table_Summary] 公司发布 2024 年报，实现收入 230.38 亿元，同比下降 9.8%，实现净利润 2.11 亿元，同比下 降 67.2%。区域市场需求整体承压，公司全年水泥板块销量同比下滑 10.9%；同时报告期内公 司管理费用 26.3 亿，相比 2023 年增加约 3 亿元，也成为业绩的一大拖累。 请阅读最后评级说明和重要声明 公司发布 2024 年报，实现收入 230.38 亿元，同比下降 9.8%，实现净利润 2.11 亿元，同比下 降 67.2%。 事件评论 ⚫ 预计公司 2025-2026 年业绩为 11、13 亿，对应 PE 为 11、9 倍，买入评级。 %% %% %% %% research.95579.com 1 华润建材科技（1313.HK） cjzqdt11111 [ ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The optical sector is expected to maintain high prosperity in 2025, with strategic adjustments in module production benefiting long-term profit fundamentals. The net profit forecast for 2025-2026 has been adjusted down to 3.5 billion and 3.8 billion respectively, with a new forecast for 2027 at 4.4 billion, representing year-on-year growth of 28%/7%/19%. The current stock price corresponds to a PE ratio of 22.4/21.0/17.6 for 2025-2027. The company is expected to benefit from three major industry drivers: mobile optical upgrades, the penetration of automotive ADAS, and the growth of XR optics, which will solidify its market position and profit base [5][6] Financial Summary and Valuation Metrics - The company's financial performance shows a significant recovery, with a net profit of 2.7 billion in 2024, a year-on-year increase of 146%, aligning with previous profit forecasts. The overall revenue and gross margin met expectations, while operating expenses exceeded expectations due to increased administrative costs from IT investments. The mobile module business has seen improvements in ASP and gross margin, with a projected gross margin of nearly 8% for 2024. The mobile lens shipment volume is expected to grow by 13% year-on-year, driven by overseas customer growth, with a gross margin of 22%. The automotive lens shipment volume is also projected to grow by 13%, slightly above guidance, with stable ASP and gross margin. The automotive module revenue is expected to reach 2.1 billion, slightly exceeding the company's guidance of 2 billion. XR-related revenue is projected to grow by 38% year-on-year, surpassing the previous guidance of 25% [5][6][8]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][12]. Core Views - The optical sector is expected to maintain high prosperity in 2025, with strategic adjustments in module production benefiting long-term profit fundamentals. The net profit forecast for 2025-2026 has been adjusted down to 3.5 billion and 3.8 billion respectively, with a new forecast for 2027 at 4.4 billion, representing year-on-year growth of 28%/7%/19%. The current stock price corresponds to a PE ratio of 22.4/21.0/17.6 for 2025-2027 [5][6]. - The company’s 2024 performance met expectations, confirming the trend of mobile optical upgrades and significant breakthroughs with overseas major clients. The net profit for 2024 was 2.7 billion, a year-on-year increase of 146%, aligning with the previous profit forecast [5][6]. Financial Summary and Valuation Metrics - Revenue and net profit projections for the company are as follows: - 2023A: Revenue of 31.681 billion, Net Profit of 1.099 billion - 2024A: Revenue of 38.294 billion, Net Profit of 2.699 billion - 2025E: Revenue of 42.499 billion, Net Profit of 3.450 billion - 2026E: Revenue of 46.189 billion, Net Profit of 3.688 billion - 2027E: Revenue of 54.522 billion, Net Profit of 4.402 billion - The year-on-year growth rates for revenue and net profit are projected to be 20.9% and 145.5% for 2024, and 11.0% and 27.8% for 2025 respectively [8].

Investment Rating - The report maintains an "Outperform" rating for Sino Biopharmaceutical [2][11][17] Core Insights - The company achieved revenue of CNY 28.9 billion in FY24, reflecting a year-on-year growth of 10.2% with a gross profit margin of 81.5% [3][14] - Innovative products are expected to drive double-digit revenue growth in FY25, particularly in oncology and surgery/analgesia segments [4][15] - The company plans to launch seven innovative products in FY25, including key candidates such as TQB3616 and Meloxicam [5][16] Financial Performance - FY24 revenue was CNY 28.9 billion, with a net profit of CNY 3.5 billion, marking a 50.1% increase year-on-year [3][14] - R&D expenses increased by 15.6% to CNY 5.1 billion, representing 17.6% of total revenue [3][14] - The company expects revenue to reach CNY 32.4 billion in FY25, a growth of 12.3% year-on-year [6][16] Segment Performance - Revenue from innovative drugs reached CNY 12.1 billion, up 22% year-on-year, while generics contributed CNY 16.8 billion, growing 3% [4][15] - The oncology segment generated CNY 10.7 billion, driven by strong sales of key products [18] - The surgery/analgesia segment saw a revenue increase of 19% to CNY 4.5 billion, primarily due to the sales of Flurbiprofen Cataplasms [18] Valuation - The target price is adjusted to HKD 5.52, based on a 2025E PE of 25.2x [6][17] - The report reflects a slight adjustment in revenue forecasts for 2025-26 due to uncertainties in biosimilar revenue growth [6][16]

Investment Rating - The report maintains a "Buy" rating for the company [1][10][11] Core Insights - The company achieved a record high gross margin of 47.0% in Q4 2024, driven by its IP strategy and strong performance in the overseas direct sales market [6][7] - Total revenue for 2024 reached 169.9 billion RMB, reflecting a year-on-year increase of 22.8% in Q4 [6][10] - The company expects revenue growth in the second half of 2025 to outpace the first half, despite a slight decrease in the number of new store openings compared to 2024 [6][10] Financial Performance - In Q4 2024, the company reported a net profit of 7.9 billion RMB, a 20.0% increase year-on-year, with an adjusted net profit margin of 16.8% [6][7] - The company’s total number of stores reached 7,504 by the end of 2024, with significant growth in overseas locations [7][10] - The adjusted EBITDA for Q4 was 12.3 billion RMB, showing a year-on-year increase of 23.3% [7] Revenue Breakdown - In Q4 2024, revenue from the Miniso brand was 44.3 billion RMB, up 21.3% year-on-year, with overseas revenue growing by 42.7% [7] - The TOPTOY brand contributed 2.8 billion RMB in revenue, marking a 50.3% increase year-on-year [7] Future Projections - Revenue is projected to grow to 208 billion RMB in 2025, with a year-on-year growth rate of 23% [10][11] - Adjusted net profit is expected to reach 32 billion RMB in 2025, reflecting a 19% increase [10][11] - The company anticipates a gradual increase in gross margin, supported by the rising contribution from overseas and IP sales [7][10]

Investment Rating - The report assigns a "Buy" rating to China Resources Beverage (02460) with a target price of HKD 18.75, indicating an expected increase of over 15% relative to the market index in the next six months [1][6][12]. Core Insights - China Resources Beverage achieved a revenue of HKD 13.521 billion in 2024, a slight increase of 0.05% year-on-year, while the net profit attributable to shareholders rose by 23.12% to HKD 1.637 billion. The company declared a total cash dividend of HKD 1.158 billion, with a payout ratio of 70.77% [3][4][5]. - The company’s packaging water segment saw a revenue decline of 2.6% to HKD 12.124 billion, accounting for 89.7% of total revenue, while the second-line beverage business grew by 30.8% to HKD 1.4 billion, representing 10.3% of total revenue [4][5]. - The gross margin improved by 2.6 percentage points to 47.3%, driven by increased self-owned production capacity and reduced outsourcing costs. The net profit margin also increased by 2.3 percentage points to 12.1% [5][6]. Summary by Sections Financial Performance - In 2024, the company reported total revenue of HKD 13.521 billion and a net profit of HKD 1.637 billion, with respective growth rates of 0.05% and 23.12% [3][7]. - The projected revenues for 2025, 2026, and 2027 are HKD 14.453 billion, HKD 15.261 billion, and HKD 16.075 billion, with growth rates of 7%, 6%, and 5% respectively [7][9]. Market Position and Strategy - The company is focusing on enhancing its market presence in the large packaging water segment, which has shown a revenue increase of 8.6% year-on-year, while small packaging products faced a decline due to competitive pricing [4][5]. - The introduction of new products, such as the "Zhi Ben Qing Run" series, has significantly boosted sales, with a 122% increase in volume for this product line [4][6]. Operational Efficiency - The report highlights that internal efficiency improvements have led to a decrease in unit production costs, contributing to a notable increase in profitability [5][6]. - The company plans to further enhance its production capacity and reduce logistics costs by expanding its distribution network and optimizing transportation methods [6][9].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company reported a revenue increase of 54% to 5.1 billion RMB in 2024, with a gross profit increase of 51% to 2.6 billion RMB [7] - The social business revenue grew rapidly, with SUGO and TOPTOP achieving triple-digit revenue growth [7] - The company has established a regional headquarters in Saudi Arabia, marking a significant milestone in its global expansion [7] - AI technology is being integrated across the company's operations, enhancing product innovation and operational efficiency [7] - The company has demonstrated a strong growth model through its "product bush + AI engine" strategy, with significant potential for future expansion in the social entertainment ecosystem [7] Financial Performance Summary - Total revenue for 2023 was 3.3 billion RMB, projected to reach 5.1 billion RMB in 2024, with a year-on-year growth rate of 53.92% [1][8] - The net profit attributable to the parent company is expected to decline slightly in 2024 to 480.31 million RMB, but is projected to rebound significantly in the following years [1][8] - The earnings per share (EPS) for 2024 is forecasted at 0.34 RMB, with a P/E ratio of 15.61 [1][8] - The company has a strong balance sheet with a debt-to-asset ratio of 53.81% and a net asset value per share of 1.09 RMB [6][8]

Investment Rating - The investment rating for TCL Electronics is "Buy" (maintained) [1] Core Views - The company reported a strong performance in 2024, with revenue reaching HKD 99.3 billion (+26%) and net profit attributable to shareholders at HKD 1.76 billion (+137%). Adjusted net profit was HKD 1.61 billion (+100%) [5][14] - The growth in sales was driven by significant improvements in both domestic and international television sales, with a notable increase in profit margins expected due to channel structure adjustments and cost control measures [5][41] - The company has revised its profit forecasts for 2025-2027, expecting net profits of HKD 2.13 billion, HKD 2.47 billion, and HKD 2.80 billion respectively, with corresponding EPS of HKD 0.8, HKD 1.0, and HKD 1.1 [5][41] Summary by Sections 1. 2024 Performance Overview - TCL Electronics achieved a revenue of HKD 99.3 billion in 2024, with a year-on-year growth of 26%. The net profit attributable to shareholders was HKD 1.76 billion, reflecting a 137% increase [14][19] - For the second half of 2024, revenue was HKD 53.8 billion (+22%) and net profit was HKD 1.11 billion (+131%) [14][41] 2. Margin and Profitability Analysis - The overall gross margin for 2024 was 15.7%, a decrease of 1.6 percentage points, primarily due to structural changes and panel cost fluctuations. However, the company managed to improve its expense ratios across various categories [22][24] - The net profit margin for 2024 was 1.77%, an increase of 0.8 percentage points, indicating effective cost management strategies [24][25] 3. North American Channel Insights - The restructuring of channels in North America has shown significant results, with an increase in the number of SKUs for high-end products at Bestbuy. For example, the number of MiniLED SKUs for 75-inch and above increased from 3 to 16 [7][28] - The company has also expanded its product offerings in Walmart, focusing on larger size products, while maintaining a stable SKU count compared to 2024 [37][40] 4. Profit Forecast and Investment Recommendations - The company has adjusted its profit forecasts for 2025-2027, with expected net profits of HKD 2.13 billion, HKD 2.47 billion, and HKD 2.80 billion respectively. The current stock price corresponds to P/E ratios of 10.4, 9.0, and 7.9 for the respective years [5][41] - The long-term outlook remains positive due to ongoing improvements in overseas channel structures and product offerings [5][41]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported a revenue growth of over 156% in 2024, reaching 2.24 billion RMB, primarily driven by the sales of building block toys [6] - The gross profit increased by 184% to 1.18 billion RMB, with the gross margin improving from 47.3% to 52.6% due to the growth in building block toy sales and economies of scale [6] - The company is focusing on expanding its overseas market and developing new IPs, with overseas revenue increasing by over 5 times [6] - The report highlights a balanced IP structure with significant growth in various IPs, reducing reliance on a single IP [6] - The adjusted net profit for 2025-2026 has been revised upwards to 10.8 billion RMB and 16.5 billion RMB, respectively, with a projected net profit of 20.9 billion RMB in 2027 [6] Financial Summary - Total revenue for 2023 was 876.69 million RMB, with projections of 2,240.93 million RMB for 2024, 3,922.35 million RMB for 2025, 5,732.48 million RMB for 2026, and 7,022.76 million RMB for 2027 [1][7] - The company reported a net loss of 401.05 million RMB in 2024, but the Non-GAAP net profit is expected to reach 584.59 million RMB in the same year [1][7] - The earnings per share (EPS) is projected to improve from -1.61 RMB in 2024 to 8.12 RMB in 2027 [1][7] - The price-to-earnings (P/E) ratio is expected to decrease from -64.91 in 2024 to 12.86 in 2027 [1][7]